Literature DB >> 15172213

In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum.

C Di Giorgio1, F Delmas, E Ollivier, R Elias, G Balansard, P Timon-David.   

Abstract

Harmane, harmine, and harmaline were investigated for their in vitro antileishmanial activity toward parasites of the species Leishmania infantum. Harmane and Harmine displayed a moderate antiproliferative activity toward human monocytes and exerted a weak antileishmanial activity toward both the promastigote and the amastigote forms of the parasite. Their mechanism of action on the promastigote form of the parasite involved interactions with DNA metabolism leading to an accumulation of parasites in the S-G(2)M phases of the cell-cycle. Harmaline, at the contrary, was deprived from toxicity toward human cells and Leishmania promastigotes, however it exerted a strong antileishmanial activity toward the intracellular amastigote form of the parasite. This property was shown to partly result from the capacity of the molecule to prevent parasite internalization within macrophages by inhibiting Leishmania PKC activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172213     DOI: 10.1016/j.exppara.2004.04.002

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  26 in total

1.  Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol.

Authors:  Mohamed A M El Gendy; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Toxicol Lett       Date:  2011-10-06       Impact factor: 4.372

2.  Exploiting the Polypharmacology of ß-Carbolines to Disrupt O. volvulus Molting.

Authors:  Major Gooyit; Nancy Tricoche; Sacha Javor; Sara Lustigman; Kim D Janda
Journal:  ACS Med Chem Lett       Date:  2015-01-20       Impact factor: 4.345

3.  Evaluation of the effect of Peganum harmala extracts on the in vitro viability of Leishmania tropica promastigotes in comparison to Glucantime.

Authors:  Manar Madah; Shaden Haddad; Mays Khazem
Journal:  J Parasit Dis       Date:  2020-09-27

4.  Beta-carboline-3-carboxamide derivatives as promising antileishmanial agents.

Authors:  R B Pedroso; L T D Tonin; T Ueda-Nakamura; B P Dias Filho; M H Sarragiotto; C V Nakamura
Journal:  Ann Trop Med Parasitol       Date:  2011-12

5.  The influence of Agrobacterium rhizogenes on induction of hairy roots and ß-carboline alkaloids production in Tribulus terrestris L.

Authors:  Sara Sharifi; Taher Nejad Sattari; Alireza Zebarjadi; Ahmad Majd; Hamidreza Ghasempour
Journal:  Physiol Mol Biol Plants       Date:  2013-11-27

6.  Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities.

Authors:  Adil Astulla; Kazumasa Zaima; Yosuke Matsuno; Yusuke Hirasawa; Wiwied Ekasari; Aty Widyawaruyanti; Noor Cholies Zaini; Hiroshi Morita
Journal:  J Nat Med       Date:  2008-06-04       Impact factor: 2.343

7.  N-butyl-[1-(4-methoxy)phenyl-9H-β-carboline]-3-carboxamide prevents cytokinesis in Leishmania amazonensis.

Authors:  T F Stefanello; M R Panice; T Ueda-Nakamura; M H Sarragiotto; R Auzély-Velty; C V Nakamura
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

8.  An insight into tetrahydro-β-carboline-tetrazole hybrids: synthesis and bioevaluation as potent antileishmanial agents.

Authors:  Pooja Purohit; Anand Kumar Pandey; Deepti Singh; Pradeep Singh Chouhan; Karthik Ramalingam; Mahendra Shukla; Neena Goyal; Jawahar Lal; Prem M S Chauhan
Journal:  Medchemcomm       Date:  2017-07-21       Impact factor: 3.597

9.  In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents.

Authors:  Maria L Alomar; Federico A O Rasse-Suriani; Agustina Ganuza; Verónica M Cóceres; Franco M Cabrerizo; Sergio O Angel
Journal:  BMC Res Notes       Date:  2013-05-10

10.  Application of the central composite design to optimize the preparation of novel micelles of harmine.

Authors:  Yong-Yan Bei; Xiao-Feng Zhou; Ben-Gang You; Zhi-Qiang Yuan; Wei-Liang Chen; Peng Xia; Yang Liu; Yong Jin; Xiao-Juan Hu; Qiao-Ling Zhu; Chun-Ge Zhang; Xue-Nong Zhang; Liang Zhang
Journal:  Int J Nanomedicine       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.